SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: F. Jay Abella, III who wrote (3387)4/16/1998 10:03:00 PM
From: Anaxagoras  Read Replies (1) of 7041
 
Look, first, Oppie isn't some bucket shop (that isn't to say, however, that their recs are never self-serving).

Second, you're vaguely suggesting that ZONA intends to do some selling of shares and Oppie is trying to position themselves for the investment banking:
<<Many times, in biotech especially, the "recommendations" are often followed by stock to sell (i.e., an S-3 filing).>>

With all the cash on hand, who do you think is gonna be selling so that the company will have to file an S-3 in the next year or so? Come on, use your imagination, tell me a story....

Anaxagoras
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext